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These data have implications for the utility of CAS, and
directions for future procedural refinements are needed to
improve outcomes. Because there is little reason to suspect
that spontaneous emboli are any larger than emboli created
by CAS, they may have implications regarding spontaneous
microembolization as well. Primarily, however, these data
serve to highlight the conundrum of microembolization to
the brain: hundreds if not thousands of microemboli were
released in these patients, yet there were a mean of only
three areas of injury per patient in this study. A similar
disconnect occurs in our experimental studies, where hun-
dreds of emboli are injected yet only a few areas of ischemic
injury develop.9 A “washout” phenomenon has been pro-
posed19 but arteriovenous connections are generally small
and the observed coincidence of hypoperfusion and em-
bolic stroke may simply reflect heightened tissue vulnera-
bility.20 Another potential explanation is that emboli mar-
ginate along the artery wall, a common fate of particulates
in flowing fluids.18,21 There, they may actually undergo
extravasation into the extravascular space.22 Although pro-
tective mechanisms exist, microemboli are important etio-
logic agents of brain ischemia and have pathologic impor-
tance in the deep structures of the brain as well as the
cortex.
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Dr Peter A. Schneider (Honolulu, Hawaii). We don’t know
where carotid stenting will go from here. I believe that carotid
stenting will play a role in the future and that further development
of this procedure will make it better and more widely applicable.ractice, and better understand the cerebrovascular anatomy we
hought we knew already.
The other thing the carotid stenting has done is push us to ask
ew questions about plaque stability and brain physiology. How
o we explain the fact that the brain handles emboli so much better
han we imagined? Do we know what a lacunar infarct is? How
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April 2011976 Zhu et alabout small vessel disease or white matter changes? The fundamen-
tal vocabulary of cerebrovascular events remains ambiguous.
We cannot look at this study in a vacuum. This group has
produced five studies over the past 3 years that have substantially
improved our knowledge of brain physiology, how the brain
handles emboli, and how carotid angioplasty and stenting (CAS)
works. Some of these were presented at the Western Vascular
Society. This represents a stepwise progression of investigation in
both the laboratory and at the bedside. They were among the first
to identify post-CAS magnetic resonance imaging (MRI) lesions.
They went on to develop a model for cholesterol emboli to the
brain, evaluated the results of distal filter vs reversed flow, and
developed a model for lacunar infarct.
This study takes us back to the bedside and asks, “What more
can we learn about brain physiology by looking at what happened
to embolic particles produced by CAS?” The brain is more resilient
than we thought, but the brain may also be keeping score. These
findings help to explain the clinical observation that neurologic
events occurring after CAS are more frequent, usually less severe,
and more often delayed than after carotid endarterectomy (CEA).
If you have hundreds of emboli by transcranial Doppler
(TCD) imaging and also in your ex vivo model, why are there only
a few lesions on MRI? Where do they go? Are certain areas more
prone to emboli? Why aren’t more of these emboli clinically
significant? How much damage is size and how much is composi-
tion? Do you think the clinical diagnosis of lacunar infarct is usually
embolic? What is this telling us about the potential causes of the
epidemic of dementia that our baby boomer population faces?
Make a prediction about whether this issue of emboli associated
with CAS can be solved.Dr Joseph Rapp. Thank you Peter for your comments and
questions. First, “What explains the brain’s apparent tolerance for
m
licroembolization?” Our theory is that these particulates margin-
te along the wall of the larger pial vessels and there are exciting
ecent data suggesting that there can be active extravasation of
hose particles that come to rest along the vessel wall. This would
ddress your third question, which is, “Why aren’t more of these
mboli clinically significant?”
Regarding whether size or composition is more important:
mbolus composition does contribute to ischemic potential, but
ize is clearly more important. Size (in this case smaller diameter)
lso determines access to the deeper regions of the brain. The work
resented today shows that emboli small enough to reach the
eriventricular white matter cause lesions in that area in numbers
hat correspond to the overall blood flow, which is relatively low.
o my mind, this proves that the ischemic lesions in this area
lacunar infarcts) could be embolic. I personally believe that this is
he dominant cause, but there are many who do not agree.
There are implications that microemboli promote dementia,
s you suggest. A study by Purandare has linked higher rates of
mboli to dementia. Furthermore, patients with known carotid
tenoses have higher rates of embolization on TCD, and Alzhei-
er’s patients with carotid stenosis deteriorate faster than patients
ith normal carotid bifurcations. The data are not definitive, but it
s cause for concern. Although most microemboli do not cause
linical effects and there may bemechanisms at work in the brain to
emove emboli, I do not believe that microemboli to the brain
hould ever be termed “benign.”
Regarding improvements to CAS to reduce embolization:
ur bench work and some single institution trials suggest that
erioperative embolization will be reduced with flow reversal as a
rotection strategy. This may help but it is not the whole story as
ost emboli occur after the procedure. What can be done about
ate emboli remains to be determined.
